![Jay Venkatesan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jay Venkatesan
Direktor/Vorstandsmitglied bei
ELICIO THERAPEUTICS, INC.
Vermögen: 2 Mio $ am 31.05.2026
Profil
Jay R.
Venkatesan founded Tangerine Technologies, Inc. in 1999, Ayer Capital Management LP in 2008, where he worked as Managing Partner, Alpine Biosciences, Inc. in 2015, where he worked as President & Director from 2016 to 2017, and various other companies.
Dr. Venkatesan also founded Varro Technologies, Inc., where he is working as President & Treasurer.
Dr. Venkatesan also currently works at Elicio Therapeutics, Inc. (United States), as Director, Eurofins Transplant Genomics LLC, as Director, Serina Therapeutics, Inc., as Independent Director from 2025, and various other companies.
Dr. Venkatesan also formerly worked at Angion Biomedica Corp., as Chairman, President & Chief Executive Officer from 2018 to 2023, Bain Capital Public Equity LP, as Director from 2002 to 2007, Targanta Therapeutics Corp., as Director from 2007 to 2008, and various other companies.
Dr. Venkatesan received his undergraduate degree in 1993 from Williams College, Masters Business Admin degree from The Wharton School of the University of Pennsylvania, and doctorate degree from the University of Pennsylvania Medical Center.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ELICIO THERAPEUTICS, INC 0,89 % | 09.04.2026 | 170.223 ( 0,89 % ) | 2 Mio $ | 31.05.2026 |
1,55 % | 17.06.2026 | 232.294 ( 1,55 % ) | 427 421 $ | 31.05.2026 |
Aktive Positionen von Jay Venkatesan
| Unternehmen | Position | Beginn |
|---|---|---|
| ELICIO THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.06.2023 |
Zylem Biosciences, Inc.
 Zylem Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company developing targeted medicines | Gründer | 01.01.2018 |
Elicio Therapeutics, Inc. (United States)
 Elicio Therapeutics, Inc. (United States) BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops novel immunotherapies for treatment of cancer and other diseases | Direktor/Vorstandsmitglied | - |
Alpine Bioventures, GP, LLC
 Alpine Bioventures, GP, LLC Investment ManagersFinance Alpine Bioventures is an active manager which invests in companies located in the United States. It targets companies operating in the fields of health technology and health services. It provides financing for seed and early stage capital requirements. | Private Equity Investor | 01.07.2015 |
Transplant Genomics, Inc.
 Transplant Genomics, Inc. BiotechnologyHealth Technology Operates as a molecular diagnostics company which focuses on kidney transplant recipients | Direktor/Vorstandsmitglied | - |
Ayer Capital Partners Master Fund LP
 Ayer Capital Partners Master Fund LP Investment Trusts/Mutual FundsMiscellaneous Acts as Hedge Fund | Corporate Officer/Principal | - |
Varro Technologies, Inc.
 Varro Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops distributed knowledge management applications for the life-science industry | Gründer | - |
Ehemalige bekannte Positionen von Jay Venkatesan
| Unternehmen | Position | Ende |
|---|---|---|
| ANGN BIOM | Vorstandsvorsitzender | 01.01.2023 |
Cell Biotherapy, Inc.
 Cell Biotherapy, Inc. BiotechnologyHealth Technology Engages in development of bio therapeutics | Direktor/Vorstandsmitglied | 01.01.2023 |
| ░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Jay Venkatesan
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
59
Beziehungen ersten Grades
30
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 30 |
|---|---|
Bain Capital Public Equity LP
 Bain Capital Public Equity LP Investment ManagersFinance Bain Capital Public Equity employs long/short equity strategies that combine rigorous bottom-up, fundamental research with analytical portfolio construction to identify and capitalize on opportunities across the global equity markets. The firm seeks to achieve isolate alpha and generate attractive returns over a full market and industry cycle with low correlation to the equity markets. Their investment advisory activity focuses on advising the Public Equity Funds on investments in securities of publicly traded companies that offer opportunities to realize substantial long-term appreciation. Bain Capital Public Equity typically makes investments in securities at prices it believes to be below their intrinsic value based on a company’s normalized cash flow, growth potential and/or asset value. | Finance |
Targanta Therapeutics Corp.
 Targanta Therapeutics Corp. BiotechnologyHealth Technology Discovers and develops novel antibacterial pro drugs | Health Technology |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Develops therapeutic products for the treatment of cancer | Health Technology |
ACM Capital Partners LLC
 ACM Capital Partners LLC Investment ManagersFinance ACM Capital Partners LLC is an active manager. | Finance |
Elicio Therapeutics, Inc. (United States)
Elicio Therapeutics, Inc. (United States) BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops novel immunotherapies for treatment of cancer and other diseases | Health Technology |
Transplant Genomics, Inc.
Transplant Genomics, Inc. BiotechnologyHealth Technology Operates as a molecular diagnostics company which focuses on kidney transplant recipients | Health Technology |
Alpine Immune Sciences, Inc. /Old/
 Alpine Immune Sciences, Inc. /Old/ BiotechnologyHealth Technology Operates as a biotechnology company which develops cancer immunotherapy systems | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Williams College
 Williams College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
REVA Medical, Inc.
 REVA Medical, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and sells implantable bio resorbable medical devices | Health Technology |
Brookside Mezzanine Partners Management LLC
 Brookside Mezzanine Partners Management LLC Investment ManagersFinance Brookside Capital Partners seeks investment opportunities in lower middle-market companies located in the United States with an revenue of USD 15 million and EBITDA of USD 4 million. The firm targets companies operating in the fields of manufacturing, business services, distribution, consumer products/retail, transportation & logistics and healthcare sectors. It provides subordinated debt and minority equity financing for strategic acquisitions, buyouts, leveraged recapitalizations, dividend payments and growth capital requirements with an investment size ranging between USD 5 - 30 million. | Finance |
Patricof & Co. Ventures, Inc.
 Patricof & Co. Ventures, Inc. Investment ManagersFinance Acts as an alternative investment manager | Finance |
Varro Technologies, Inc.
Varro Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops distributed knowledge management applications for the life-science industry | Commercial Services |
Tangerine Technologies, Inc.
 Tangerine Technologies, Inc. Packaged SoftwareTechnology Services Provides software development and business process outsourcing solutions | Technology Services |
Ayer Capital Management LP
 Ayer Capital Management LP Investment ManagersFinance Ayer Capital Management manages a global healthcare long/short equity hedge fund. The firm invests across all market-caps and maintains a very high turnover rate | Finance |
Ayer Capital Partners Master Fund LP
Ayer Capital Partners Master Fund LP Investment Trusts/Mutual FundsMiscellaneous Acts as Hedge Fund | Miscellaneous |
Iovance Biotherapeutics, Inc.
 Iovance Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotechnological products for the treatment of cancer | Health Technology |
Exicure Operating Co.
 Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Develops immunomodulatory and gene regulating drugs | Health Technology |
Tivorsan Pharmaceuticals, Inc.
 Tivorsan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics for the treatment of neuromuscular disorders | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Angion Biomedica Corp.
 Angion Biomedica Corp. Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products | Health Technology |
Alpine Biosciences, Inc.
 Alpine Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development of protocells for treatment of rare diseases and cancer | Commercial Services |
University of Pennsylvania Medical Center
 University of Pennsylvania Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alpine Bioventures, GP, LLC
Alpine Bioventures, GP, LLC Investment ManagersFinance Alpine Bioventures is an active manager which invests in companies located in the United States. It targets companies operating in the fields of health technology and health services. It provides financing for seed and early stage capital requirements. | Finance |
Alpine Bioventures LP
 Alpine Bioventures LP Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Alpine Immune Sciences, Inc.
 Alpine Immune Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as an bio pharmaceutical company that develops immunotherapies for autoimmune and inflammatory diseases | Health Technology |
Exicure, Inc.
 Exicure, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops nucleic acid therapies against to neurological disorders and hair loss | Health Technology |
Cell Biotherapy, Inc.
Cell Biotherapy, Inc. BiotechnologyHealth Technology Engages in development of bio therapeutics | Health Technology |
Zylem Biosciences, Inc.
Zylem Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company developing targeted medicines | Health Technology |
Elicio Therapeutics, Inc.
 Elicio Therapeutics, Inc. BiotechnologyHealth Technology Develops cancer immunotherapies | Health Technology |
Wählen Sie MarketScreener 
